Alta Partners Management Company, L.P. Tyra Biosciences, Inc. Transaction History
Alta Partners Management Company, L.P.
- $60 Billion
- Q3 2025
A detailed history of Alta Partners Management Company, L.P. transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Alta Partners Management Company, L.P. holds 4,080,296 shares of TYRA stock, worth $63.4 Million. This represents 95.15% of its overall portfolio holdings.
Number of Shares
4,080,296
Previous 4,080,296
-0.0%
Holding current value
$63.4 Million
Previous $39 Billion
46.19%
% of portfolio
95.15%
Previous 93.82%
Shares
1 transactions
Others Institutions Holding TYRA
# of Institutions
116Shares Held
58.4MCall Options Held
23.5KPut Options Held
0-
Ra Capital Management, L.P. Boston, MA12.2MShares$190 Million2.93% of portfolio
-
Nextech Invest Ag4.06MShares$63 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$63 Million8.64% of portfolio
-
Bvf Inc San Francisco, CA3.65MShares$56.7 Million2.76% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA3.61MShares$56.1 Million99.51% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $652M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...